Simon Rothwell

Simon Rothwell's work experience begins in 2008 as a Research Technician at The University of Manchester. Simon then worked as a Research Assistant at the same institution from June 2013 to August 2016, where they were responsible for data collection, statistical analysis, and manuscript development. During their time at UCL, they also worked as a Private A-level Biology Tutor at Fleet Tutors from September 2015 to June 2016.

In 2016, Simon joined Evidera as a Market Access Writer, where they contributed to various projects related to market access, including global value dossiers and advisory reports. Simon then transitioned to the role of Market Access Writer II at Evidera from November 2017 to January 2018, expanding their responsibilities to include disease and treatment areas such as Parkinson's Disease and oncology.

Simon moved to PAREXEL in January 2018, where they initially worked as a Senior Associate in the Pricing and Market Access team. In this position, they delivered value communication and primary research projects for neurology and oncology healthcare products. Simon then advanced to the role of Consultant in November 2018, taking on additional responsibilities such as managing value communication and primary research projects, developing real-world observational studies, and contributing to thought leadership activities.

Simon's most recent experience is at Eisai EMEA, where they have held several roles. Simon started as a Senior Manager in Global Market Access in July 2019, leading strategies for reimbursement and market access. Simon was promoted to Associate Director in July 2021 and then to Director in February 2022. In their current role, they lead Eisai's Global Market Access team in optimizing patient access and reimbursement for their branded treatment portfolio and pipeline.

Overall, Simon Rothwell has developed a strong background in market access, pricing, and healthcare consultancy, specializing in neurology and oncology products.

Simon Rothwell completed their education at The University of Manchester. Simon obtained a Bachelor of Science (BSc) degree in Pharmacology with honors in the years 2004 to 2008. Following this, they pursued a Doctor of Philosophy (PhD) degree in Cellular and Molecular Neuroscience from 2009 to 2013. In addition to their academic qualifications, Simon also holds certifications in Legal and Ethical Guidelines for Market Researchers and Adverse Event Reporting in Market Research, both obtained in 2019 from the British Healthcare Business Intelligence Association.